LPL Financial
LJPC

LPL Financial’s La Jolla Pharmaceutical Company LJPC Stock Holding History

LPL Financial’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,640
Closed -$98K – 3444
2019
Q2 		$98K Hold
10,640
– – ﹤0.01% 3154
2019
Q1 		$68K Hold
10,640
– – ﹤0.01% 3100
2018
Q4 		$100K Sell
10,640
-335
-3% -$5.04K ﹤0.01% 2956
2018
Q3 		$221K Hold
10,975
– – ﹤0.01% 2927
2018
Q2 		$320K Sell
10,975
-1,525
-12% -$47.1K ﹤0.01% 2591
2018
Q1 		$372K Sell
12,500
-1,000
-7% -$32.2K ﹤0.01% 2418
2017
Q4 		$434K Buy
+13,500
New +$441K ﹤0.01% 2180

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

LPL Financial's LJPC Position: Q3 2019 in Review

LPL Financial sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2019, closing a stake of 10,640 shares — an estimated $98K sold.

LPL Financial first reported a position in LJPC in Q4 2017 and held it in 7 quarters. The position peaked at $434K in Q4 2017. 75 funds tracked by Wall St. Rank hold LJPC as of Q3 2019.

  • LPL Financial reported no remaining La Jolla Pharmaceutical Company position as of Q3 2019 after selling out during the quarter.
  • LPL Financial sold 10,640 La Jolla Pharmaceutical Company shares in Q3 2019, an estimated $98K.
  • LPL Financial first reported a position in La Jolla Pharmaceutical Company in Q4 2017 and held it in 7 quarters.
  • LPL Financial's La Jolla Pharmaceutical Company position peaked at $434K in Q4 2017.
  • 75 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2019.

Based on LPL Financial's 13F filing for Q3 2019, filed 13 Nov 2019.